SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank43
3Y CAGR-29.5%
5Y CAGR-39.6%
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

3Y CAGR
-29.5%/yr
Annual compound
5Y CAGR
-39.6%/yr
Recent acceleration
Percentile
P43
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202515.96%
2024144.69%
2023-44.80%
202245.61%
2021-5.86%
2020198.43%
2019-43.78%
2018-44.83%
20174.62%
201627.20%